£45.00
PT-141 10mg from Adaptog Peptides, also known as Bremelanotide, is a synthetic melanocortin receptor agonist used in research on the central melanocortin system. Investigators select PT-141 for its activity at MC3R and MC4R receptors, which makes it a valuable tool for studies on neural signalling, sexual-response pathways, and energy-balance regulation. Adaptog supplies PT-141 10mg at consistent laboratory-grade purity.
PT-141 was developed as a melanocortin agonist with selectivity that distinguishes it from earlier melanotan compounds. Its activity at central melanocortin receptors places it at the centre of research programmes investigating neural-behavioural pathways, appetite regulation, and reproductive signalling. Adaptog Peptides supplies PT-141 10mg as a high-purity reagent suited to receptor-binding and pharmacology studies.
Researchers often buy PT-141 10mg from Adaptog Peptides for tasks such as:
Investigating MC3R and MC4R receptor activation and binding kinetics
Examining central pathways involved in sexual-response research
Studying melanocortin involvement in feeding behaviour and energy balance
Comparing the pharmacological profile of PT-141 against other melanocortin agonists
Because PT-141 is a well-characterised melanocortin agonist, it supports detailed work in receptor pharmacology and behavioural neuroscience. Adaptog Peptides delivers PT-141 10mg as a research-grade compound prepared strictly for qualified laboratory environments. It is not for clinical, diagnostic, or therapeutic use.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
